Latest News - #Microgen

Rostec and RDIF will start to produce medication for the treatment of coronavirus

Holding "national immunobiological company" the state Corporation "rostec" and the Russian direct investment Fund (RDIF) will begin to release drug based on blood plasma for the treatment of COVID-19, production is scheduled to deploy immediately on four grounds stated in the joint message of the companies.

"The partnership between RDIF and holding "national immunobiological company" involves the production of an immunoglobulin preparation that contains antibodies to the coronavirus SARS CoV-2. It will be made on the basis of plasma donors who have had coronavirus infection", - stated in the message.